US2020357516A1PendingUtilityA1
Systems and methods for automatically interpreting images of microbiological samples
Assignee: BETH ISRAEL DEACONESS MEDICAL CT INCPriority: Nov 21, 2017Filed: Nov 20, 2018Published: Nov 12, 2020
Est. expiryNov 21, 2037(~11.3 yrs left)· nominal 20-yr term from priority
C12Q 1/04G06V 20/698G06V 10/82G06V 10/454G06V 10/764G16H 50/20G06N 3/045G06F 18/24G06F 18/214G06N 3/0464G06N 3/09G06N 3/096G06V 2201/03Y02A90/10G16H 30/40G06T 7/0012G06N 3/08G16H 40/60G06K 9/6256G06K 9/6267
41
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
In accordance with some embodiments of the disclosed subject matter, provided herein are mechanisms (which can, for example, include systems, methods, and media) for automatically interpreting and classifying images of Gram-stained biological samples.
Claims
exact text as granted — not AI-modified1 . A method for automatically classifying a biological sample, comprising:
receiving an image of the biological sample; extracting a plurality of image patches from the image; providing each of the plurality of image patches to a trained convolution neural network that was trained using transfer learning and a plurality of images of pre-classified and labeled biological samples; receiving, for each of the plurality of image patches, a classification from the trained convolution neural network indicating a prediction that the image patch includes an example of a particular class of a plurality of classes; counting, for each of the plurality of classes, the number of image patches predicted by the trained classifier to include examples of the class; and classifying, based on the count for each of the plurality of classes, the biological sample.
2 . The method of claim 1 , wherein the biological sample is a Gram-stained blood culture slide.
3 . The method of claim 2 , wherein the plurality of classes includes at least a first class corresponding to Gram-negative rods, a second class corresponding to Gram-positive cocci in clusters, and a third class corresponding to Gram-positive cocci in pairs and chains.
4 . The method of claim 2 , wherein the plurality of classes includes one or more classes selected from the group consisting of Gram-negative cocci in pairs, Gram-negative coccobacilli, Gram-positive coccobacilli, Gram positive cocci in pairs, Gram-positive diptheroidal morphologies, Gram-positive bacilli/clostridial morphologies, and Gram-positive rods in chains.
5 . The method of claim 1 , wherein the trained convolution neural network is a version of an Inception v3 convolution neural network.
6 . The method of claim 5 , wherein the Inception v3 convolution neural network was trained to classify a multitude of different object classes from input image data using labeled images including examples of the different object classes, wherein each of the plurality of classes is different than all of the different object classes.
7 . The method of claim 6 , wherein a final fully connected layer of the Inception v3 convolution neural network was retrained using the plurality of images of pre-classified and labeled biological samples.
8 . The method of claim 1 , wherein the biological sample comprises at least one of the following liquids: blood, plasma, serum, sputum, saliva, bronchoalveolar lavage fluid, lymph, urine, pleural fluid, ascites fluid, synovial fluid, and fluid obtained by irrigating or washing a body cavity.
9 . (canceled)
10 . The method of claim 8 , wherein the plurality of classes includes at least a first class corresponding to the presence of a first organism, and a second class corresponding to absence of the first organism.
11 . The method of claim 8 , wherein the biological sample comprises sputum, wherein the plurality of classes includes at least a first class corresponding to the presence of a squamous epithelial cell, and wherein the method further comprises determining the prevalence of squamous epithelial cells in the sputum.
12 . The method of claim 1 , wherein the biological sample comprises a fluid prepared using an acid-fast stain.
13 . The method of claim 12 , wherein the fluid comprises sputum or bronchoalveolar lavage fluid.
14 . The method of claim 13 , wherein the plurality of classes includes at least a first class corresponding to the presence of mycobacteria, and a second class corresponding to the absence of mycobacteria.
15 . The method of claim 1 , wherein the biological sample comprises Löwenstein-Jensen medium or Middlebrook broth with presumptive mycobacteria prepared using acid-fast stain.
16 . The method of claim 15 , wherein the plurality of classes includes at least a first class corresponding to the presence of one or more acid-fast organisms.
17 . The method of claim 1 , wherein the biological sample comprises a fluid sample prepared using fluorescent probes.
18 . The method of claim 17 , wherein the fluid comprises sputum or bronchoalveolar lavage fluid.
19 . The method of claim 18 , wherein the plurality of classes includes at least a first class corresponding to the presence of a first type of organism, and a second class corresponding to the presence of a second organism.
20 . The method of claim 1 , wherein the biological sample comprises a stool sample prepared using fluorescent probes.
21 . The method of claim 20 , wherein the plurality of classes includes at least a first class corresponding to the presence of Cryptosporidium or Giardia , and a second class corresponding to the absence of Cryptosporidium or Giardia.
22 . The method of claim 1 , wherein classifying the biological sample comprises classifying the biological sample based on the class having the highest count or classifying the biological sample based on one or more classes having a count over a threshold.
23 . (canceled)
24 . The method of claim 22 , wherein each of the one or more classes is associated with a threshold, and the threshold for a first class is different than a threshold for a second class.Join the waitlist — get patent alerts
Track US2020357516A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.